Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hibiki Udagawa

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 21, 2019
Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burdenTomoyuki Naito, Hibiki Udagawa, Shigeki Umemura, et al.
Journal of Cancer Research and Clinical Oncology|January 10, 2015
Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lungHibiki Udagawa, Genichiro Ishii, Masahiro Morise, et al.
Journal of Cancer Research and Clinical Oncology|September 30, 2020
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancerTetsuya Sakai, Hibiki Udagawa, Shingo Matsumoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancerMasaki Nakamura, Shun-Ichiro Kageyama, Hibiki Udagawa, et al.
Frontiers in Pharmacology|October 30, 2018
Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma CellsYuzo Sato, Shiori Matsuda, Ami Maruyama, et al.
Cancer Science|May 20, 2020
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm studyHibiki Udagawa, Keisuke Kirita, Tomoyuki Naito, et al.
Journal of Cancer Research and Clinical Oncology|April 10, 2016
The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lungKazunori Hata, Junji Yoshida, Hibiki Udagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysisHibiki Udagawa, Shigeki Umemura, Isao Murakami, et al.
Cancer Treatment and Research Communications|May 13, 2025
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancerYu Tanaka, Hiroki Izumi, Eri Sugiyama, et al.
Molecular Cancer Research : MCR|September 29, 2023
Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung CarcinomaSho Tabata, Shigeki Umemura, Miyu Narita, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|October 21, 2019
Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burdenTomoyuki Naito, Hibiki Udagawa, Shigeki Umemura, et al.
Journal of Cancer Research and Clinical Oncology|January 10, 2015
Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lungHibiki Udagawa, Genichiro Ishii, Masahiro Morise, et al.
Journal of Cancer Research and Clinical Oncology|September 30, 2020
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancerTetsuya Sakai, Hibiki Udagawa, Shingo Matsumoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancerMasaki Nakamura, Shun-Ichiro Kageyama, Hibiki Udagawa, et al.
Frontiers in Pharmacology|October 30, 2018
Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma CellsYuzo Sato, Shiori Matsuda, Ami Maruyama, et al.
Cancer Science|May 20, 2020
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm studyHibiki Udagawa, Keisuke Kirita, Tomoyuki Naito, et al.
Journal of Cancer Research and Clinical Oncology|April 10, 2016
The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lungKazunori Hata, Junji Yoshida, Hibiki Udagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysisHibiki Udagawa, Shigeki Umemura, Isao Murakami, et al.
Cancer Treatment and Research Communications|May 13, 2025
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancerYu Tanaka, Hiroki Izumi, Eri Sugiyama, et al.
Molecular Cancer Research : MCR|September 29, 2023
Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung CarcinomaSho Tabata, Shigeki Umemura, Miyu Narita, et al.
Pageof 6